Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

Keros Therapeutics KER-012 shows promise for the treatment of PAH

May 20, 2021

Eccogene (Shanghai) identifies SSAO inhibitors

May 19, 2021

Promising effect of oral TRPC6 inhibitor BI-749327 on pulmonary hypertension

May 18, 2021

Sunshine Lake Pharma describes new mineralocorticoid receptor antagonists

May 14, 2021

Cereno and University of Michigan collaborate on preclinical development of CS-585

April 30, 2021

Enrollment opens in phase II/III study of MK-5475 in PAH

April 30, 2021

Vicore Pharma discloses AGTR2 agonists

April 9, 2021

CD38 inhibition as a potent new therapeutic approach against ischemic brain injury

April 6, 2021

Vazkepa approved in E.U. to reduce cardiovascular risk in adults with elevated triglycerides

March 30, 2021

Cholesterol-independent heart disease risk gene

March 29, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...